Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanib.

Autor:	Pilco Teran, Melissa, Merino Ribas, Ana, Martin Alemany, Nadia, Barros Freiria, Xoana, Rubio Casadevall, Jordi, Pérez Bueno, Ferran, García Méndez, Isabel, Castillo Devia, Marcela, Noboa Paez, Cristina, Torguet Escuder, Pere, Calabia Martínez, Jordi
Předmět:	CANCER cells INTERSTITIAL nephritis THYROID gland tumors PROTEIN-tyrosine kinase inhibitors ACUTE diseases
Zdroj:	Investigational New Drugs; 2021, Vol. 39 Issue 1, p237-239, 3p
Abstrakt:	Summary: Few cases of immunoallergic tubulointerstitial nephritis associated with tyrosine kinase inhibitors have been described. We describe the first report case associated with vandetanib, a tyrosine kinase inhibitor indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (CMT) in patients with locally advanced or metastatic non-resectable disease. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink